What is the current size of the mycoplasma testing market?

The market is valued at USD 1.13 billion in 2025 and is forecast to reach USD 1.93 billion by 2030. Read More

Which segment is growing the fastest?

Gene & Cell Therapy Manufacturing is projected to grow at 17.82% CAGR due to strict contamination-control requirements. Read More

Why are CMOs gaining share in mycoplasma testing?

Biotech firms are outsourcing manufacturing and quality control to CMOs to access validated laboratories without large capital outlays, pushing CMO demand up at 15.45% CAGR. Read More

How do regulatory mandates influence market growth?

FDA and EMA rules make mycoplasma testing mandatory before product release, creating non-discretionary spending that raises overall market CAGR. Read More

Which technology is disrupting traditional methods?

Digital PCR offers absolute quantification with detection limits around 10 CFU/mL, expanding at 16.26% CAGR as labs replace culture-based assays. Read More

What restrains rapid adoption of automated platforms?

High upfront costs of USD 100,000–500,000 and shortages of trained molecular-QA staff delay automation, particularly in smaller labs. Read More

Mycoplasma Testing Companies

This report lists the top Mycoplasma Testing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Mycoplasma Testing industry.

About This Report
- Market Size & Share
- Market Analysis
- Trends and Insights
- Segment Analysis
- Geography Analysis
- Competitive Landscape
- Major Players
- Recent Developments
Table of Contents
SCOPE OF THE REPORT
Market Definition